Measurement plan

Everything here ties back to one business goal: reduce 90-day new-hire turnover from 22% to 15% within 12 months (see the performance gap). Completion rates are tracked only as a sanity check — they are not outcomes.

All baseline values are simulated (constructed for portfolio purposes); the design is what’s being demonstrated. In a real engagement, the baseline comes from HRIS and the pulse survey.

Indicators

Type Metric Source Baseline (simulated) Target When
Leading % of managers holding one-on-ones at least every two weeks Calendar audit (sampled) + manager self-report 31% (22 of 70) 80% Monthly
Leading Scenario completion + debrief reflection submitted Scenario log + one-question reflection n/a (new) 90% of managers 6 weeks post-launch
Leading Job aid usage (one-on-ones where the structure was used, manager self-report) 30-day challenge tracker n/a (new) 60% 30 days, then quarterly
Behavior Staff pulse item: “I received useful feedback in the last 2 weeks” (1–5) Quarterly pulse survey 2.4/5 (n=130) 3.5/5 Quarterly; reach 3.5 within 2 quarters
Behavior Staff reporting a regular fortnightly 1:1 Pulse survey 35% (45 of 130) 60% Quarterly
Lagging 90-day new-hire turnover HRIS 22% (17 of 78) 15% 12 months (reported quarterly)
Guardrail Clinic throughput (patients/day) and wait-time variance Ops dashboards current levels no deterioration Monthly

The guardrail row matters politically: this intervention asks managers to spend time on people. If throughput degrades, the blend loses leadership support — so it is measured, not assumed away.

Isolating the contribution: staggered rollout

Clinic-level change alone can’t prove the blend caused it. The rollout is staggered so unrolled clinics act as a comparison group:

  • Wave 1 (month 1): 6 clinics — the two with the worst 90-day turnover plus the two best, plus two middle performers.
  • Wave 2 (month 3): the remaining 6 clinics.

Read-outs: compare the change in each indicator between waves (difference-in-differences). If Wave 1 clinics move on the leading and behavior indicators before Wave 2 clinics do — and the gap closes when Wave 2 launches — the blend is the most plausible explanation. The survey analysis shows why clinic-level comparison is meaningful (clinic correlates with structure, which is exactly what the blend changes).

Sample honesty: 12 clinics is 12 clusters; the comparison is directional evidence, not a trial. With 70 managers, monthly cadence percentages move in steps of ~1.4 points per manager — report confidence intervals or at minimum the raw counts, never bare percentages alone.

Confounds — named in advance

Confound Why it matters Mitigation
Labor market shifts A tightening market lifts turnover everywhere (or a slump masks gains) Track the regional health-care vacancy rate alongside; compare waves
Pay changes The 2026 award review lands mid-year Log the date; test whether turnover moved at the pay event, not the intervention
Clinic leadership changes New managers reset everything at once HRIS change log; exclude clinics with manager changes from the primary comparison
Seasonality Flu waves distort rosters and turnover in winter Use year-over-year comparisons for the same quarter
Hawthorne effect Managers behave better while observed in wave 1 The behavior indicator runs a full year; the 6- and 12-month read-outs matter more than month 1

Review cadence

When What happens Who
Monthly (months 1–6) Cadence % + guardrails; flag clinics below 60% cadence to ops directors L&D + HR
6 weeks Scenario completion + reflection themes; first pulse read L&D
Quarterly Full pulse + turnover vs. comparison group; steering decision: continue / adjust / stop COO + HR + L&D
12 months Primary read-out: 90-day turnover vs. 15% target; write-up goes to the board COO

Pre-registered stop/adjust rule: if at 6 months the cadence indicator is ≥ 70% but the pulse item has not moved at least +0.4, the problem is content (the meetings happen but aren’t working — the Cedar Point pattern), and the fix is coaching on the template, not more pressure on cadence.

What this plan can and cannot show

  • Can: whether the leading indicators move; whether behavior change precedes the turnover change in the wave order the blend predicts; whether turnover and guardrails move together.
  • Cannot (simulated case): anything real — there was no deployment. The baselines were constructed for portfolio purposes. Even in a real run, a 12-clique staggered rollout is evidence, not proof; attribution would stay qualified.